Company News

bioMérieux and JMI Laboratories (JMI) are announcing a six-year partnership to undertake collaborative projects evaluating the performance and increasing potential of rapid and innovative microbiology diagnostics as important tools in the battle against AMR.

bioMérieux has developed a MONKEYPOX R-GENE® PCR kit. Available for research use only (RUO), this kit can easily be used by laboratories around the world.

bioMérieux is making a $5 million investment in InDevR, and will be the exclusive distributor in Europe of VaxArray®, a state-of-the-art vaccine quality control platform developed by the American company.

These certifications demonstrate the quality of our HR strategy and rewards the commitment of our HR teams who work every day to improve the employee experience at bioMérieux! The Top Employer seal also impacts our attractiveness by telling candidates that we care about our people!